Biochips-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Biochips-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biochips industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biochips 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biochips worldwide and market share by regions, with company and product introduction, position in the Biochips market
Market status and development trend of Biochips by types and applications
Cost and profit status of Biochips, and marketing status
Market growth drivers and challenges
The report segments the global Biochips market as:
Global Biochips Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biochips Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA chips
Lab-on-a-chip
Protein chips
Global Biochips Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology
Genomics and proteomics
Drug screening and development
Molecular diagnostics
Microfluidic technologie
Microarray and biosensors
Global Biochips Market: Manufacturers Segment Analysis (Company and Product introduction, Biochips Sales Volume, Revenue, Price and Gross Margin):
Affymetric Inc
Illumina Inc
GE Healthcare Ltd
Agilent Technologies Inc
Roche NimbleGen
Life Technologies Corporation
EMD Millipore
Bio-Rad Laboratories Inc
Abbott Laboratories
Fluidigm Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biochips-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biochips industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biochips 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biochips worldwide and market share by regions, with company and product introduction, position in the Biochips market
Market status and development trend of Biochips by types and applications
Cost and profit status of Biochips, and marketing status
Market growth drivers and challenges
The report segments the global Biochips market as:
Global Biochips Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biochips Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA chips
Lab-on-a-chip
Protein chips
Global Biochips Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology
Genomics and proteomics
Drug screening and development
Molecular diagnostics
Microfluidic technologie
Microarray and biosensors
Global Biochips Market: Manufacturers Segment Analysis (Company and Product introduction, Biochips Sales Volume, Revenue, Price and Gross Margin):
Affymetric Inc
Illumina Inc
GE Healthcare Ltd
Agilent Technologies Inc
Roche NimbleGen
Life Technologies Corporation
EMD Millipore
Bio-Rad Laboratories Inc
Abbott Laboratories
Fluidigm Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOCHIPS
1.1 Definition of Biochips in This Report
1.2 Commercial Types of Biochips
1.2.1 DNA chips
1.2.2 Lab-on-a-chip
1.2.3 Protein chips
1.3 Downstream Application of Biochips
1.3.1 Biotechnology
1.3.2 Genomics and proteomics
1.3.3 Drug screening and development
1.3.4 Molecular diagnostics
1.3.5 Microfluidic technologie
1.3.6 Microarray and biosensors
1.4 Development History of Biochips
1.5 Market Status and Trend of Biochips 2013-2023
1.5.1 Global Biochips Market Status and Trend 2013-2023
1.5.2 Regional Biochips Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biochips 2013-2017
2.2 Sales Market of Biochips by Regions
2.2.1 Sales Volume of Biochips by Regions
2.2.2 Sales Value of Biochips by Regions
2.3 Production Market of Biochips by Regions
2.4 Global Market Forecast of Biochips 2018-2023
2.4.1 Global Market Forecast of Biochips 2018-2023
2.4.2 Market Forecast of Biochips by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biochips by Types
3.2 Sales Value of Biochips by Types
3.3 Market Forecast of Biochips by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biochips by Downstream Industry
4.2 Global Market Forecast of Biochips by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biochips Market Status by Countries
5.1.1 North America Biochips Sales by Countries (2013-2017)
5.1.2 North America Biochips Revenue by Countries (2013-2017)
5.1.3 United States Biochips Market Status (2013-2017)
5.1.4 Canada Biochips Market Status (2013-2017)
5.1.5 Mexico Biochips Market Status (2013-2017)
5.2 North America Biochips Market Status by Manufacturers
5.3 North America Biochips Market Status by Type (2013-2017)
5.3.1 North America Biochips Sales by Type (2013-2017)
5.3.2 North America Biochips Revenue by Type (2013-2017)
5.4 North America Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biochips Market Status by Countries
6.1.1 Europe Biochips Sales by Countries (2013-2017)
6.1.2 Europe Biochips Revenue by Countries (2013-2017)
6.1.3 Germany Biochips Market Status (2013-2017)
6.1.4 UK Biochips Market Status (2013-2017)
6.1.5 France Biochips Market Status (2013-2017)
6.1.6 Italy Biochips Market Status (2013-2017)
6.1.7 Russia Biochips Market Status (2013-2017)
6.1.8 Spain Biochips Market Status (2013-2017)
6.1.9 Benelux Biochips Market Status (2013-2017)
6.2 Europe Biochips Market Status by Manufacturers
6.3 Europe Biochips Market Status by Type (2013-2017)
6.3.1 Europe Biochips Sales by Type (2013-2017)
6.3.2 Europe Biochips Revenue by Type (2013-2017)
6.4 Europe Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biochips Market Status by Countries
7.1.1 Asia Pacific Biochips Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biochips Revenue by Countries (2013-2017)
7.1.3 China Biochips Market Status (2013-2017)
7.1.4 Japan Biochips Market Status (2013-2017)
7.1.5 India Biochips Market Status (2013-2017)
7.1.6 Southeast Asia Biochips Market Status (2013-2017)
7.1.7 Australia Biochips Market Status (2013-2017)
7.2 Asia Pacific Biochips Market Status by Manufacturers
7.3 Asia Pacific Biochips Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biochips Sales by Type (2013-2017)
7.3.2 Asia Pacific Biochips Revenue by Type (2013-2017)
7.4 Asia Pacific Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biochips Market Status by Countries
8.1.1 Latin America Biochips Sales by Countries (2013-2017)
8.1.2 Latin America Biochips Revenue by Countries (2013-2017)
8.1.3 Brazil Biochips Market Status (2013-2017)
8.1.4 Argentina Biochips Market Status (2013-2017)
8.1.5 Colombia Biochips Market Status (2013-2017)
8.2 Latin America Biochips Market Status by Manufacturers
8.3 Latin America Biochips Market Status by Type (2013-2017)
8.3.1 Latin America Biochips Sales by Type (2013-2017)
8.3.2 Latin America Biochips Revenue by Type (2013-2017)
8.4 Latin America Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biochips Market Status by Countries
9.1.1 Middle East and Africa Biochips Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biochips Revenue by Countries (2013-2017)
9.1.3 Middle East Biochips Market Status (2013-2017)
9.1.4 Africa Biochips Market Status (2013-2017)
9.2 Middle East and Africa Biochips Market Status by Manufacturers
9.3 Middle East and Africa Biochips Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biochips Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biochips Revenue by Type (2013-2017)
9.4 Middle East and Africa Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIOCHIPS
10.1 Global Economy Situation and Trend Overview
10.2 Biochips Downstream Industry Situation and Trend Overview
CHAPTER 11 BIOCHIPS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biochips by Major Manufacturers
11.2 Production Value of Biochips by Major Manufacturers
11.3 Basic Information of Biochips by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biochips Major Manufacturer
11.3.2 Employees and Revenue Level of Biochips Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIOCHIPS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Affymetric Inc
12.1.1 Company profile
12.1.2 Representative Biochips Product
12.1.3 Biochips Sales, Revenue, Price and Gross Margin of Affymetric Inc
12.2 Illumina Inc
12.2.1 Company profile
12.2.2 Representative Biochips Product
12.2.3 Biochips Sales, Revenue, Price and Gross Margin of Illumina Inc
12.3 GE Healthcare Ltd
12.3.1 Company profile
12.3.2 Representative Biochips Product
12.3.3 Biochips Sales, Revenue, Price and Gross Margin of GE Healthcare Ltd
12.4 Agilent Technologies Inc
12.4.1 Company profile
12.4.2 Representative Biochips Product
12.4.3 Biochips Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc
12.5 Roche NimbleGen
12.5.1 Company profile
12.5.2 Representative Biochips Product
12.5.3 Biochips Sales, Revenue, Price and Gross Margin of Roche NimbleGen
12.6 Life Technologies Corporation
12.6.1 Company profile
12.6.2 Representative Biochips Product
12.6.3 Biochips Sales, Revenue, Price and Gross Margin of Life Technologies Corporation
12.7 EMD Millipore
12.7.1 Company profile
12.7.2 Representative Biochips Product
12.7.3 Biochips Sales, Revenue, Price and Gross Margin of EMD Millipore
12.8 Bio-Rad Laboratories Inc
12.8.1 Company profile
12.8.2 Representative Biochips Product
12.8.3 Biochips Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories Inc
12.9 Abbott Laboratories
12.9.1 Company profile
12.9.2 Representative Biochips Product
12.9.3 Biochips Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.10 Fluidigm Corporation
12.10.1 Company profile
12.10.2 Representative Biochips Product
12.10.3 Biochips Sales, Revenue, Price and Gross Margin of Fluidigm Corporation
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOCHIPS
13.1 Industry Chain of Biochips
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIOCHIPS
14.1 Cost Structure Analysis of Biochips
14.2 Raw Materials Cost Analysis of Biochips
14.3 Labor Cost Analysis of Biochips
14.4 Manufacturing Expenses Analysis of Biochips
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Biochips in This Report
1.2 Commercial Types of Biochips
1.2.1 DNA chips
1.2.2 Lab-on-a-chip
1.2.3 Protein chips
1.3 Downstream Application of Biochips
1.3.1 Biotechnology
1.3.2 Genomics and proteomics
1.3.3 Drug screening and development
1.3.4 Molecular diagnostics
1.3.5 Microfluidic technologie
1.3.6 Microarray and biosensors
1.4 Development History of Biochips
1.5 Market Status and Trend of Biochips 2013-2023
1.5.1 Global Biochips Market Status and Trend 2013-2023
1.5.2 Regional Biochips Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biochips 2013-2017
2.2 Sales Market of Biochips by Regions
2.2.1 Sales Volume of Biochips by Regions
2.2.2 Sales Value of Biochips by Regions
2.3 Production Market of Biochips by Regions
2.4 Global Market Forecast of Biochips 2018-2023
2.4.1 Global Market Forecast of Biochips 2018-2023
2.4.2 Market Forecast of Biochips by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biochips by Types
3.2 Sales Value of Biochips by Types
3.3 Market Forecast of Biochips by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biochips by Downstream Industry
4.2 Global Market Forecast of Biochips by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biochips Market Status by Countries
5.1.1 North America Biochips Sales by Countries (2013-2017)
5.1.2 North America Biochips Revenue by Countries (2013-2017)
5.1.3 United States Biochips Market Status (2013-2017)
5.1.4 Canada Biochips Market Status (2013-2017)
5.1.5 Mexico Biochips Market Status (2013-2017)
5.2 North America Biochips Market Status by Manufacturers
5.3 North America Biochips Market Status by Type (2013-2017)
5.3.1 North America Biochips Sales by Type (2013-2017)
5.3.2 North America Biochips Revenue by Type (2013-2017)
5.4 North America Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biochips Market Status by Countries
6.1.1 Europe Biochips Sales by Countries (2013-2017)
6.1.2 Europe Biochips Revenue by Countries (2013-2017)
6.1.3 Germany Biochips Market Status (2013-2017)
6.1.4 UK Biochips Market Status (2013-2017)
6.1.5 France Biochips Market Status (2013-2017)
6.1.6 Italy Biochips Market Status (2013-2017)
6.1.7 Russia Biochips Market Status (2013-2017)
6.1.8 Spain Biochips Market Status (2013-2017)
6.1.9 Benelux Biochips Market Status (2013-2017)
6.2 Europe Biochips Market Status by Manufacturers
6.3 Europe Biochips Market Status by Type (2013-2017)
6.3.1 Europe Biochips Sales by Type (2013-2017)
6.3.2 Europe Biochips Revenue by Type (2013-2017)
6.4 Europe Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biochips Market Status by Countries
7.1.1 Asia Pacific Biochips Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biochips Revenue by Countries (2013-2017)
7.1.3 China Biochips Market Status (2013-2017)
7.1.4 Japan Biochips Market Status (2013-2017)
7.1.5 India Biochips Market Status (2013-2017)
7.1.6 Southeast Asia Biochips Market Status (2013-2017)
7.1.7 Australia Biochips Market Status (2013-2017)
7.2 Asia Pacific Biochips Market Status by Manufacturers
7.3 Asia Pacific Biochips Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biochips Sales by Type (2013-2017)
7.3.2 Asia Pacific Biochips Revenue by Type (2013-2017)
7.4 Asia Pacific Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biochips Market Status by Countries
8.1.1 Latin America Biochips Sales by Countries (2013-2017)
8.1.2 Latin America Biochips Revenue by Countries (2013-2017)
8.1.3 Brazil Biochips Market Status (2013-2017)
8.1.4 Argentina Biochips Market Status (2013-2017)
8.1.5 Colombia Biochips Market Status (2013-2017)
8.2 Latin America Biochips Market Status by Manufacturers
8.3 Latin America Biochips Market Status by Type (2013-2017)
8.3.1 Latin America Biochips Sales by Type (2013-2017)
8.3.2 Latin America Biochips Revenue by Type (2013-2017)
8.4 Latin America Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biochips Market Status by Countries
9.1.1 Middle East and Africa Biochips Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biochips Revenue by Countries (2013-2017)
9.1.3 Middle East Biochips Market Status (2013-2017)
9.1.4 Africa Biochips Market Status (2013-2017)
9.2 Middle East and Africa Biochips Market Status by Manufacturers
9.3 Middle East and Africa Biochips Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biochips Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biochips Revenue by Type (2013-2017)
9.4 Middle East and Africa Biochips Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIOCHIPS
10.1 Global Economy Situation and Trend Overview
10.2 Biochips Downstream Industry Situation and Trend Overview
CHAPTER 11 BIOCHIPS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biochips by Major Manufacturers
11.2 Production Value of Biochips by Major Manufacturers
11.3 Basic Information of Biochips by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biochips Major Manufacturer
11.3.2 Employees and Revenue Level of Biochips Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIOCHIPS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Affymetric Inc
12.1.1 Company profile
12.1.2 Representative Biochips Product
12.1.3 Biochips Sales, Revenue, Price and Gross Margin of Affymetric Inc
12.2 Illumina Inc
12.2.1 Company profile
12.2.2 Representative Biochips Product
12.2.3 Biochips Sales, Revenue, Price and Gross Margin of Illumina Inc
12.3 GE Healthcare Ltd
12.3.1 Company profile
12.3.2 Representative Biochips Product
12.3.3 Biochips Sales, Revenue, Price and Gross Margin of GE Healthcare Ltd
12.4 Agilent Technologies Inc
12.4.1 Company profile
12.4.2 Representative Biochips Product
12.4.3 Biochips Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc
12.5 Roche NimbleGen
12.5.1 Company profile
12.5.2 Representative Biochips Product
12.5.3 Biochips Sales, Revenue, Price and Gross Margin of Roche NimbleGen
12.6 Life Technologies Corporation
12.6.1 Company profile
12.6.2 Representative Biochips Product
12.6.3 Biochips Sales, Revenue, Price and Gross Margin of Life Technologies Corporation
12.7 EMD Millipore
12.7.1 Company profile
12.7.2 Representative Biochips Product
12.7.3 Biochips Sales, Revenue, Price and Gross Margin of EMD Millipore
12.8 Bio-Rad Laboratories Inc
12.8.1 Company profile
12.8.2 Representative Biochips Product
12.8.3 Biochips Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories Inc
12.9 Abbott Laboratories
12.9.1 Company profile
12.9.2 Representative Biochips Product
12.9.3 Biochips Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.10 Fluidigm Corporation
12.10.1 Company profile
12.10.2 Representative Biochips Product
12.10.3 Biochips Sales, Revenue, Price and Gross Margin of Fluidigm Corporation
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOCHIPS
13.1 Industry Chain of Biochips
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIOCHIPS
14.1 Cost Structure Analysis of Biochips
14.2 Raw Materials Cost Analysis of Biochips
14.3 Labor Cost Analysis of Biochips
14.4 Manufacturing Expenses Analysis of Biochips
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
